PL1937245T3 - Związek użyteczny w zapobieganiu i leczeniu przerostu lewej komory u pacjentów dializowanych - Google Patents
Związek użyteczny w zapobieganiu i leczeniu przerostu lewej komory u pacjentów dializowanychInfo
- Publication number
- PL1937245T3 PL1937245T3 PL06807318T PL06807318T PL1937245T3 PL 1937245 T3 PL1937245 T3 PL 1937245T3 PL 06807318 T PL06807318 T PL 06807318T PL 06807318 T PL06807318 T PL 06807318T PL 1937245 T3 PL1937245 T3 PL 1937245T3
- Authority
- PL
- Poland
- Prior art keywords
- prevention
- treatment
- left ventricular
- ventricular hypertrophy
- compound useful
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Road Signs Or Road Markings (AREA)
- Finger-Pressure Massage (AREA)
- Professional, Industrial, Or Sporting Protective Garments (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/250,634 US20070087975A1 (en) | 2005-10-17 | 2005-10-17 | Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients |
| PCT/EP2006/067465 WO2007045639A1 (en) | 2005-10-17 | 2006-10-16 | Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients |
| EP06807318A EP1937245B1 (en) | 2005-10-17 | 2006-10-16 | Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1937245T3 true PL1937245T3 (pl) | 2011-09-30 |
Family
ID=37661169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06807318T PL1937245T3 (pl) | 2005-10-17 | 2006-10-16 | Związek użyteczny w zapobieganiu i leczeniu przerostu lewej komory u pacjentów dializowanych |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20070087975A1 (pl) |
| EP (1) | EP1937245B1 (pl) |
| JP (1) | JP5106403B2 (pl) |
| AT (1) | ATE506946T1 (pl) |
| CY (1) | CY1112144T1 (pl) |
| DE (1) | DE602006021594D1 (pl) |
| DK (1) | DK1937245T3 (pl) |
| ES (1) | ES2364189T3 (pl) |
| PL (1) | PL1937245T3 (pl) |
| PT (1) | PT1937245E (pl) |
| SI (1) | SI1937245T1 (pl) |
| WO (1) | WO2007045639A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101209975B (zh) * | 2006-12-29 | 2010-12-01 | 沈阳科硕营养科技有限公司 | 左旋肉碱富马酸钙及其制备方法与用途 |
| EP2353596A1 (en) | 2010-02-02 | 2011-08-10 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1156741B (it) * | 1978-05-15 | 1987-02-04 | Sigma Tau Ind Farmaceuti | Applicazione terapeutica della carnitina e di alcuni derivati acilati della carnitina nell'emodialisi |
| IT1156852B (it) * | 1978-07-10 | 1987-02-04 | Sigma Tau Ind Farmaceuti | Procedimento industriale per la preparazione del d'canforato della l carnitinammide e del d canforato della d carnitinammide e sue applicazioni |
| US4434816A (en) * | 1978-10-30 | 1984-03-06 | Giovanni Bernard A Di | Service line interior by-pass fitting |
| US4968719A (en) * | 1989-04-03 | 1990-11-06 | Sigma Tau, Industrie Farmaceutiche Riunite Spa | Method for treating vascular disease |
| IT1277147B1 (it) * | 1995-01-20 | 1997-11-04 | Sigma Tau Ind Farmaceuti | Uso della carnitina e i suoi derivati per ridurre gli effetti tossici della ciclosporina-a e di altri farmaci immunosoppressivi. |
| IT1290801B1 (it) * | 1996-07-05 | 1998-12-11 | Mendes Srl | Uso della acetil l-carnitina, della isovaleril l-carnitina, della propionil l-carnitina o dei loro sali farmacologicamente accettabili |
| IT1294227B1 (it) * | 1997-08-01 | 1999-03-24 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica contenente l-carnitina o una alcanoil l-carnitina e alcoli alifatici a lunga catena utile per la prevenzione |
| ES2270620T3 (es) * | 1999-10-11 | 2007-04-01 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Uso de l-carnitina y sus derivados alcanoilo como agentes osmoticos en soluciones para uso medico. |
| FR2846886A1 (fr) * | 2002-11-08 | 2004-05-14 | Merck Sante Sas | Utilisation de fosinopril pour diminuer les evenements cardiovasculaires chez des patients dialyses |
-
2005
- 2005-10-17 US US11/250,634 patent/US20070087975A1/en not_active Abandoned
-
2006
- 2006-10-16 US US12/066,032 patent/US20080234373A1/en not_active Abandoned
- 2006-10-16 DE DE602006021594T patent/DE602006021594D1/de active Active
- 2006-10-16 EP EP06807318A patent/EP1937245B1/en not_active Not-in-force
- 2006-10-16 SI SI200631051T patent/SI1937245T1/sl unknown
- 2006-10-16 JP JP2008536039A patent/JP5106403B2/ja not_active Expired - Fee Related
- 2006-10-16 DK DK06807318.8T patent/DK1937245T3/da active
- 2006-10-16 AT AT06807318T patent/ATE506946T1/de active
- 2006-10-16 PT PT06807318T patent/PT1937245E/pt unknown
- 2006-10-16 ES ES06807318T patent/ES2364189T3/es active Active
- 2006-10-16 WO PCT/EP2006/067465 patent/WO2007045639A1/en active Application Filing
- 2006-10-16 PL PL06807318T patent/PL1937245T3/pl unknown
-
2011
- 2011-07-13 CY CY20111100677T patent/CY1112144T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2009511619A (ja) | 2009-03-19 |
| DE602006021594D1 (de) | 2011-06-09 |
| EP1937245A1 (en) | 2008-07-02 |
| JP5106403B2 (ja) | 2012-12-26 |
| WO2007045639A8 (en) | 2007-06-14 |
| ES2364189T3 (es) | 2011-08-26 |
| PT1937245E (pt) | 2011-07-06 |
| SI1937245T1 (sl) | 2011-11-30 |
| US20080234373A1 (en) | 2008-09-25 |
| DK1937245T3 (da) | 2011-08-08 |
| US20070087975A1 (en) | 2007-04-19 |
| WO2007045639A1 (en) | 2007-04-26 |
| ATE506946T1 (de) | 2011-05-15 |
| CY1112144T1 (el) | 2015-11-04 |
| EP1937245B1 (en) | 2011-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY148723A (en) | Use of pinolenic acid for the treatment of obesity | |
| MY145590A (en) | Phenylacetamides and their use as glucokinase modulators | |
| MX2009006742A (es) | Inhibidores acilaminopirazoles como fgfr. | |
| TW200635582A (en) | Medicaments for the treatment or prevention of fibrotic diseases | |
| DE50311898D1 (de) | Fredericamycin-derivate als arzneimittel zur tumorbehandlung | |
| WO2007038459A3 (en) | Carboxyamine compounds and their use in the treatment of hdac dependent diseases | |
| NZ593199A (en) | Milnacipran for the long-term treatment of fybromyalgia syndrome | |
| HK1118011A1 (zh) | 透明質酸的抗腫瘤生物結合物或以化學接合方法間接地取得的衍生物，以及其製藥用途 | |
| IL186544A (en) | Use of Acid 3,1 - Propandysulfonic or Sodium Salt in the Preparation of Pharmaceuticals for the Treatment of aa Amyloidosis and Pharmaceuticals for the Treatment of aa Amyloidosis | |
| TW200635595A (en) | Medicaments for the treatment of prevention of fibrotic diseases | |
| CY1110182T1 (el) | Ιδεβενονη για τη θεραπεια των μυϊκων δυστροφιων | |
| UA96969C2 (en) | Acylaminopyrazoles as fgfr inhibitors | |
| HK1078460A1 (en) | Use of l-carnitine, actyl l-carnitine and propionyl l-carnitine in the manufacture of a combined medicament for the treatment of oligoasthenoteratospermia | |
| PT1937245E (pt) | Composto útil para a prevenção e o tratamento de hipertrofia ventricular esquerda em pacientes dialisados | |
| EP2193789A4 (en) | USE OF 3,5-DIHYDROTOLUENE OR ITS DERIVATIVES IN THE PREPARATION OF MEDICINAL PRODUCTS OR FUNCTIONAL FOOD FOR THE TREATMENT OR PREVENTION OF DEPRESSION | |
| MX2009005503A (es) | Uso de l-carnitina para la preparacion de un medicamento en forma de gotas oculares para el tratamiento de enfermedades de la cornea. | |
| IL174134A0 (en) | Use of a protein in the preparation of a medicament for treatment of fibrotic diseases | |
| WO2005049483A3 (de) | Reaktive chlorverbindungen, deren derivate, anionen und salze sowie verfahren zu deren herstellung und verwendung | |
| GB0313386D0 (en) | Treatment of disease | |
| WO2006117624A3 (en) | Kynurenic acid and salts thereof for the prevention and treatment of shock | |
| GEP20104911B (en) | Medicinal agent for preventing progression of apoptotic and jugulating necrotic changes in the organism tissues | |
| HK1135030A1 (en) | Composition useful for the treatment of type 2 diabetes | |
| DE60222662D1 (de) | Verwendung von l-azetylcarnitin zur herstellung eines medikaments zur präventiven post-chirurgischen schmerzbehandlung | |
| WO2005060978A3 (en) | Polymetaphosphate based formulations for therapy of microcrystalline arthropathies | |
| SI1824472T1 (sl) | Uporaba acetil-l-karnitina za zdravljenje fibromialgiäśnega sindroma |